国家级资质落地！毓璜顶医院获批烟威首家“中国血友病治疗中心”

Core Viewpoint - The establishment of the "China Hemophilia Treatment Center" at Yantai Yuhuangding Hospital marks a significant advancement in the treatment and management of hemophilia, a rare and complex disease, enhancing the overall diagnostic and therapeutic capabilities for patients in the region [1][5]. Group 1: Event Overview - The on-site evaluation and awarding ceremony for the "China Hemophilia Treatment Center" took place at Yantai Yuhuangding Hospital, attended by experts from the China Hemophilia Alliance and other medical professionals [1]. - The event included a comprehensive assessment of the hospital's capabilities in treating hemophilia, involving multiple clinical departments and specialists [3][5]. Group 2: Expert Evaluation - Experts conducted thorough evaluations of various aspects of hemophilia treatment, including patient information registration, diagnosis, laboratory testing, drug supply, multidisciplinary collaboration, emergency treatment processes, rehabilitation, and follow-up education [3][5]. - The evaluation process lasted nearly six months, with a focus on treatment standards, equipment configuration, team building, and patient management [5]. Group 3: Recognition and Future Plans - Yantai Yuhuangding Hospital successfully passed the certification process, becoming the first medical institution in Yantai and Weifang to receive national-level hemophilia treatment certification [5]. - The hospital's leadership expressed commitment to further improving the hemophilia treatment system and providing high-quality medical services to patients in Yantai and surrounding provinces [9].